REGENXBIO Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,087.00
6,120.00
7,588.00
4,589.00
10,393.00
218,505
Cost of Goods Sold (COGS) incl. D&A
324.00
1,007.00
1,503.00
959.00
4,395.00
13,622
Gross Income
5,763.00
5,113.00
6,085.00
3,630.00
5,998.00
204,883
SG&A Expense
10,525.00
8,812.00
29,191.00
69,072.00
81,767.00
116,741
EBIT
4,762.00
3,699.00
23,106.00
65,442.00
75,885.00
88,100
Non Operating Income/Expense
14.00
17.00
31.00
102.00
-
100
Interest Expense
611.00
321.00
20.00
-
-
-
Pretax Income
5,387.00
4,003.00
22,811.00
63,402.00
73,169.00
104,116
Income Tax
-
-
-
435.00
-
4,179
Consolidated Net Income
5,387.00
4,003.00
22,811.00
62,967.00
73,169.00
99,937
Net Income
5,387.00
4,003.00
22,811.00
62,967.00
73,169.00
99,937
Net Income After Extraordinaries
5,387.00
4,003.00
23,570.00
62,967.00
73,169.00
99,937
Net Income Available to Common
5,809.00
4,818.00
24,558.00
62,967.00
73,169.00
99,937
EPS (Basic)
0.22
0.18
2.68
2.38
2.45
2.73
Basic Shares Outstanding
26,295.70
26,295.70
9,173.00
26,409.00
29,878.00
33,427
EPS (Diluted)
0.22
0.18
2.59
2.38
2.45
2.73
Diluted Shares Outstanding
26,295.70
26,295.70
9,173.00
26,409.00
29,878.00
36,648
EBITDA
-
-
23,026.00
64,898.00
73,199.00
92,082
Other Operating Expense
-
-
-
-
116.00
42
Non-Operating Interest Income
-
-
346.00
1,938.00
2,716.00
16,116
Preferred Dividends
422.00
815.00
1,747.00
-
-
-
About REGENXBIO
View Profile
